Skip to main content
Feedback to SSRN
Feedback
(required)
Email
(required)
Submit
Yu-Nan Tian
Chinese Academy of Sciences (CAS) - Division of Anti-Tumor Pharmacology
Beijing
China
Learn more about SSRN Profiles
SCHOLARLY PAPERS
1
DOWNLOADS
41
TOTAL CITATIONS
0
Feedback
Scholarly Papers (1)
Sort by:
Paper Title, A-Z
Paper Title, Z-A
Author Name, A-Z
Author Name, Z-A
Date Posted, Ascending
Date Posted, Descending
Downloads, Ascending
Downloads, Descending
Citations, Ascending
Citations, Descending
Actions:
Email selected abstracts
View:
Selected
Original List
All Versions
Hide All Versions
All Abstracts
Hide All Abstracts
(Rank)
1.
Glycogen Synthase Kinase 3β Inhibition Synergizes with PARP Inhibitors Through the Induction of Homologous Recombination Deficiency in Colorectal Cancer
Number of pages: 44
Posted: 27 Aug 2020
Ning Zhang
, Yu-Nan Tian,
Li-Na Zhou
,
Meng-Zhu Li
,
Shan-Shan Song
,
Xia-Juan Huan
,
Xu-Bing Bao
,
Ao Zhang
,
Ze-Hong Miao
and
Jin-Xue He
Chinese Academy of Sciences (CAS) - Division of Anti-Tumor Pharmacology, Chinese Academy of Sciences (CAS) - Division of Anti-Tumor Pharmacology, Chinese Academy of Sciences (CAS) - Division of Anti-Tumor Pharmacology, Chinese Academy of Sciences (CAS) - Division of Anti-Tumor Pharmacology, Chinese Academy of Sciences (CAS) - Division of Anti-Tumor Pharmacology, Chinese Academy of Sciences (CAS) - Division of Anti-Tumor Pharmacology, Chinese Academy of Sciences (CAS) - Division of Anti-Tumor Pharmacology, Chinese Academy of Sciences (CAS) - Department of Medicinal Chemistry, Chinese Academy of Sciences (CAS) - Division of Anti-Tumor Pharmacology and Chinese Academy of Sciences (CAS) - Division of Anti-Tumor Pharmacology
Downloads
41
(1,170,409)
View PDF
Download
Abstract:
PARP inhibitor, GSK3β, homologous recombination repair, BRCA1, colorectal cancer
Feedback
